Brian Clevinger
InvestorFounder and Managing Director at Prolog Ventures · Board director at Plastomics, Inc. · Board director at Toma Biosciences
About
A co-founder and managing director of Prolog with over 25 years in bioscience commercialization. He previously served as CEO of vaccine developer Megan Health (1993 until its 2000 acquisition by AVANT Immunotherapeutics), led Alafi Capital's medical technology commercialization partnership A/W Company with Washington University, and held a tenured research position at Washington University; he holds a doctorate in immunology from Indiana University.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Plastomics, Inc.
Intro paths
In turn, Brian can intro founders to Plastomics, Inc.'s investors below.
Plastomics, Inc.'s investors · 7
Board director at Toma Biosciences
Intro paths
In turn, Brian can intro founders to Toma Biosciences's investors below.
Toma Biosciences's investors · 1
Deals · 2
Plastomics, Inc.Board seat
via Prolog Ventures · filed Mar 2021 · $3.5M raise
Toma BiosciencesBoard seat
via Prolog Ventures · filed Sep 2016 · $16.1M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Prolog Ventures
Frequently asked questions
- Who is Brian Clevinger?
- A co-founder and managing director of Prolog with over 25 years in bioscience commercialization. He previously served as CEO of vaccine developer Megan Health (1993 until its 2000 acquisition by AVANT Immunotherapeutics), led Alafi Capital's medical technology commercialization partnership A/W Company with Washington University, and held a tenured research position at Washington University; he holds a doctorate in immunology from Indiana University.
- Where does Brian Clevinger work?
- Brian Clevinger is Founder and Managing Director at Prolog Ventures and Board director at Plastomics, Inc. and Board director at Toma Biosciences.
- What does Brian Clevinger invest in?
- Brian Clevinger invests in Biotech.
- What boards does Brian Clevinger sit on?
- Brian Clevinger holds tracked board seats at Plastomics, Inc., Toma Biosciences.